Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV+ adults: Evidence for a legacy effect?

Journal of NeuroVirology

Volumn 20, Issue 1, 2014, Pages 85-98

  Iudicello, Jennifer E ^a   Morgan, Erin E ^a   Gongvatana, Assawin ^a   Letendre, Scott L ^b   Grant, Igor ^a   Woods, Steven Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Aging; Comorbidities; Disability; HIV associated neurocognitive disorders; Neuropsychology; Substance use

Indexed keywords

METHAMPHETAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; COCAINE DEPENDENCE; COGNITION; COMORBIDITY; DEPENDENT PERSONALITY DISORDER; EMPLOYMENT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL PERFORMANCE; METHAMPHETAMINE DEPENDENCE; MOOD DISORDER; NEUROTOXICITY; PRESCRIPTION; PRIORITY JOURNAL; SUBSTANCE ABUSE;

ADULT; AGE FACTORS; AMPHETAMINE-RELATED DISORDERS; COGNITION DISORDERS; FEMALE; HIV INFECTIONS; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84896723930     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-014-0233-y     Document Type: Article

References (71)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington
2. Ances BM, Vaida F, Yeh MJ, Liang CL, Buxton RB, Letendre S, McCutchan JA, Ellis RJ (2010) HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. J Infect Dis 201(3):336-340. doi: 10.1086/649899
3. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd D, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799. doi: 10.1212/01.WNL.0000287431.88658.8
4. Becker JT, Kingsley L, Mullen J, Cohen B, Martin E, Miller EN, Ragin A, Sacktor N, Selnes OA, Visscher BR (2009) Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology 73:1292-1299. doi: 10.1212/WNL.0b013e3181bd10e7
5. Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore DJ, Franklin DR, Ellis RJ, Grant I, Woods SP, the TMARC Group (2013) Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use. J Addict Med 7:255-263. doi: 10.1097/ADM. 0b013e318293653d
6. Buchacz K, McFarland W, Kellogg TA, Loeb L, Holmberg SD, Dilley J, Klausner JD (2005) Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 19:1423-1424
7. Buttner A (2011) Review: the neuropathology of drug abuse. Neuropathol Appl Neurobiol 37:118-134. doi: 10.1111/j.1365-2990.2010.01131.x
8. Byrd DA, Fellows RP, Morgello S, Franklin DR, Heaton RK, Deutsch R, Atkinson JH, Clifford DB, Collier AC, Marra CM, Gelmen B, McCutchan JA, Duarte NA, Simpson DM, McArthur J, Grant I, the CHARTER Group (2011) Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr 58:154-162. doi: 10.1097/QAI.0b013e318229ba41
9. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK, the HNRC Group (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307-319
10. Carrico AW (2011) Substance use and HIV disease progression in the HAART era: implications for the primary prevention of HIV. Life Sci 88:940-947. doi: 10.1016/j.lfs.2010.10.002
11. Cattie JE, Montoya JL, Morgan EE, Woods SP, Grant I, the TMARC Group (2013) Longer abstinence from methamphetamine is associated with better neurocognitive performance in younger but not older adults [Abstract]. 75th Annual Meeting of the College on Problems of Drug Dependence
12. Chana G, Everall IP, Crews L, Langford D, Adame A, Grant I, Cherner M, Lazzaretto D, Heaton RK, Ellis RJ, Masliah E, the HNRC Group (2006) Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology 67:1486-1489. doi: 10.1212/01.wnl.0000240066.02404.e6
13. Chang L, Ernst T, Speck O, Grob CS (2005) Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry 162:361-369. doi: 10.1176/appi.ajp.162.2.361
14. Culbertson WC, Zillmer EA (2001) The tower of London DX (TOLDX) manual. Multi-Health Systems, North Tonawanda, NY
15. Delis DC, Kramer JH, Kaplan E, Ober BA (2000) The California Verbal Learning Test (2nd ed). The Psychological Corporation, San Antonio
16. Doyle K, Morgan EE, Morris S, Smith DM, Little S, Iudicello JE, Blackstone K, Moore DJ, Grant I, Letendre SL, Woods SP, the TMARC Group (2013) Real-world impact of neurocognitive deficits in acute and early HIV infection. J Neurovirol 19:565-573. doi: 10.1007/s13365-013-0218-2
17. Ellis RJ, Chiders ME, Cherner M, Lazzaretto D, Letendre S, Grant I, the HNRC Group (2003) Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis 188:1820-1826
18. Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, McCutchan JA, Grant I, the CHARTER Group (2011) CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS 25:1747-1751. doi: 10.1097/QAD. 0b013e32834a40cd
19. Fama R, Rosenbloom MJ, Sassoon SA, Thompson MA, Pfefferbaum A, Sullivan EV (2011) Remote semantic memory for public figures in HIV infection, alcoholism, and their comorbidity. Alcohol Clin Exp Res 35:265-276. doi: 10.1111/j.1530-0277.2010.01342.x
20. Foley J, Ettenhofer M, Wright MJ, Siddiqi I, Choi M, Thames AD, Mason K, Castellon S, Hinkin CH (2010) Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age. Clin Neuropsychol 24:265-285. doi: 10.1080/13854040903482830
21. Gannon P, Khan MZ, Kolson DL (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 24:275-283. doi: 10.1097/WCO.0b013e32834695fb
22. Gavrilin MA, Mathes LE, Podell M (2002) Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J Neurovirol 8:240-249. doi: 10.1080/13550280290049660
23. Gongvatana A, Woods SP, Taylor MJ, Vigil O, Grant I (2007) Semantic clustering inefficiency in HIV-associated dementia. J Neuropsychiatry Clin Neurosci 19:36-42
24. Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, Berti A, Rossi E, Roverato A, Palella F (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53:1120-1126. doi: 10.1093/cid/cir627
25. Heaton RK, Miller SW, Taylor MJ, Grant I (2004) Revised comprehensive norms for an expanded Halstead-Reitan Battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Psychological Assessment Resources, Inc., Lutz
26. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt M, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, the CHARTER Group, the HNRC Group (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16. doi: 10.1007/s13365-010-0006-1
27. Hedden T, Gabrieli JD (2004) Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 5:82-96. doi: 10.1038/nrn1323
28. Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, Thrasher D, Goetz MB, Stefaniak M (2002) Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 59:1944-1950
29. Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, Stefaniak M (2004) Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and, substance abuse. AIDS 18(Suppl 1):S19-25
30. Hinkin CH, Barclay TR, Castellon SA, Levine AJ, Durvasula RS, Marion SD, Myers HF, Longshore D (2007) Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav 11:185-194. doi: 10.1007/s10461-006-9152-0
31. Iudicello JE, Woods SP, Vigil O, Scott JC, Cherner M, Heaton RK, Atkinson JH, Grant I, the HNRC Group (2010) Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence. J Clin Exp Neuropsychol 32:704-718. doi: 10.1080/ 13803390903512637
32. Iudicello JE, Kellogg EJ, Weber E, Smith C, Grant I, Drane DL, Woods SP, the HNRP Group (2012a) Semantic cueing improves category verbal fluency in persons living with HIV infection. J Neuropsychiatry Clin Neurosci 24:183-190. doi: 10.1176/appi.neuropsych.11100301
33. Iudicello JE, Woods SP, Deutsch R, Grant I, the HNRP Group (2012b) Combined effects of aging and HIV infection on semantic verbal fluency: a view of the cortical hypothesis through the lens of clustering and switching. J Clin Exp Neuropsychol 34:476-488. doi: 10.1080/13803395.2011.651103
34. Johnson T, Nath A (2011) Immune reconstitution inflammatory syndrome and the central nervous system. Curr Opin Neurol 24:284-290. doi: 10.1097/WCO.0b013e328346be57
35. Kilbourne AM, Justice AC, Rabeneck L, Rodriguez-Barradas M, Weissman S, VACS 3 Project Team (2001) General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era. J Clin Epidemiol 54:S22-S28
36. Kløve H (1963) Clinical neuropsychology. In: Forster FM (ed) The medical clinics of North America. Saunders, New York
37. Langford TD, Everall IP, Masliah E (2011) Neuronal injury, white matter disease, and neurotropic factors. In: Gendelman HE, Grant I, Everall IP, Fox HS, Gelbard HA, Lipton SA, Swindells S (eds) The neurology of AIDS, 3rd edn. Oxford University Press, New York, pp 619-632
38. Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179-186
39. Lescure FX, Moulignier A, Savatovsky J, Amiel C, Carcelain G, Molina JM, Gallien S, Pacanovski J, Pialoux G, Adle-Biassette H, Gray F (2013) CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity. Clin Infect Dis 57:101-108. doi: 10.1093/cid/cit175
40. Letendre SL, Cherner M, Ellis RJ, Marquie-Beck J, Gragg B, Marcotte T, Heaton RK, McCutchan JA, Grant I, the HNRC Group (2005) The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS 19:S72-S78
41. Magalhães MG, Greenberg B, Hansen H, Glick M (2007) Comorbidities in older patients with HIV: a retrospective study. J Am Dent Assoc 138:1468-1475
42. Mahajan SD, Aalinkeel R, Sykes DE, Reynolds JL, Bindukumar B, Adal A, Qi M, Toh K, Xu G, Prasad PN, Schwartz SA (2008) Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res 1203:133-148. doi: 10.1016/j.brainres.2008.01.093
43. May MT, Ingle SM (2011) Life expectancy of HIV-positive adults: a review. Sex Health 8:526-533. doi: 10.1071/SH11046
44. McCann UD, Kuwabara H, Kumar A, Palermo M, Abbey R, Brasic J, Ye W, Alexander M, Dannals RF, Wong DF, Ricaurte GA (2008) Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 62:91-100. doi: 10.1002/syn.20471
45. McNair DM, Lorr M, Droppleman LF (1981) Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego
46. Morgan EE, Iudicello JE, Weber E, Duarte NA, Riggs PK, Delano-Wood L, Ellis RJ, Grant I, Woods SP (2012) Synergistic effects of HIV infection and older age on daily functioning. J Acquir Immune Defic Syndr 61:341-348. doi: 10.1097/QAI.0b013e31826bfc53
47. Norman MA, Moore DJ, Taylor M, Franklin DR, Cysique L, Ake C, Lazarretto D, Vaida F, Heaton RK, the HNRC Group (2011) Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol 33:793-804. doi: 10.1080/13803395.2011.559157
48. Nyenhuis D, Yamamoto C, Luchetta T, Terrien A, Parmentier A (1999) Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 55:79-86
49. Onen NF, Overton ET, Seyfried W, Stumm ER, Snell M, Mondy K, Tebas P (2010) Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV Clin Trials 11:100-109. doi: 10.1310/hct1102-100
50. Polesskaya O, Silva J, Sanfilippo C, Desrosiers T, Sun A, Shen J, Feng C, Polesskiy A, Deane R, Zlokovic B, Kasischke K, Dewhurst S (2011) Methamphetamine causes sustained depression in cerebral blood flow. Brain Res 1373:91-100. doi: 10.1016/j.brainres.2010.12.017
51. Psychological Corporation (1997) WAIS-III and WMS-III technical manual. Psychological Corporation, San Antonio
52. Psychological Corporation (2001) Wechsler test of adult reading. Psychological Corporation, San Antonio
53. Reger M, Welsh R, Razani J, Martin DJ, Boone KB (2002) A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc 8:410-424
54. Reitan RM, Wolfson D (1985) The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Neuropsychology Press, Tucson
55. Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I, the HNRC Group (2004) Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 10:1-14
56. Rodriguez-Penney AT, Iudicello JE, Riggs PK, Doyle K, Ellis RJ, Letendre SL, Grant I, Woods SP, The HNRP Group (2013) Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDs 27:5-16. doi: 10.1089/apc.2012.0329
57. Substance Abuse and Mental Health Services Administration (SAMHSA) (2012) Results from the 2011 National Survey on drug use and health: summary of national findings. Substance Abuse and Mental Health Services Administration, Rockville
58. Tomaszewski Farias S, Cahn-Weiner DA, Harvey DJ, Reed BR, Mungas D, Kramer JH, Chui H (2009) Longitudinal changes in memory and executive functioning are associated with longitudinal change in instrumental activities of daily living in older adults. Clin Neuropsychol 23:446-461. doi: 10.1080/13854040802360558
59. Valcour VG, Shikuma CM, Shiramizu B, Watters M, Poff P, Selnes O, Holck P, Grove J, Sacktor NC (2004a) Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort. Neurology 63:822-827
60. Valcour VG, Shikuma CM, Watters MR, Sacktor NC (2004b) Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. AIDS 18:S79-S86
61. Valcour VG, Paul R, Neuhaus J, Shikuma CM (2011) The effects of age and HIV on neuropsychological performance. J Int Neuropsychol Soc 17:190-195. doi: 10.1017/S135561771000438
62. Verhaeghen P, Salthouse TA (1997) Meta-analyses of age-cognition relations in adulthood: estimates of linear and nonlinear age effects and structural models. Psychol Bull 122:231-249
63. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J (2001) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21:9414-9418
64. Weber E, Blackstone K, Iudicello JE, Morgan EE, Grant I, Moore DJ, Woods SP, the TMARC Group (2012) Neurocognitive deficits are associated with unemployment in chronic methamphetamine users. Drug Alcohol Depend 125:146-153. doi: 10.1016/j.drugalcdep.2012.04.002
65. Weber E, Blackstone K, Woods SP (2013a) Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action. Neuropsychol Rev 23:81-98. doi: 10.1007/s11065-013-9225-6
66. Weber E, Morgan EE, Iudicello JE, Blackstone K, Grant I, Ellis RJ, Letendre SL, Little S, Morris S, Smith DM, Woods SP, the TMARC Group (2013b) Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. J Neurovirol 19:65-74. doi: 10.1007/s13365-012-0141-y
67. Woods SP, Rippeth JD, Conover E, Gongvatana A, Gonzalez R, Carey CL, Cherner M, Heaton RK, Grant I, the HNRC Group (2005a) Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 19:35-43. doi: 10.1037/0894-4105.19.1.35
68. Woods SP, Scott JC, Sires DA, Grant I, Heaton RK, Tröster AI, the HNRC Group (2005b) Action (verb) fluency: test-retest reliability, normative standards, and construct validity. J Int Neuropsychol Soc 11:408-415
69. Woods SP, Moore DJ, Weber E, Grant I (2009) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19:152-168. doi: 10.1007/s11065-009-9102-5
70. Woods SP, Dawson MS, Weber E, Grant I, the HNRC Group (2010) The semantic relatedness of cue-intention pairings influences event-based prospective memory failures in older adults with HIV infection. J Clin Exp Neuropsychol 32:398-407. doi: 10.1080/13803390903130737
71. World Health Organization (1998) Composite International Diagnostic Interview (CIDI, Version 2.1). World Health Organization, Geneva